PATHEON UK LIMITED

03764421
Active United Kingdom

Manufacture of basic pharmaceutical products

444 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparations +2
P

PATHEON UK LIMITED

03764421

Manufacture of basic pharmaceutical products

Founded 29 Apr 1999 Active United Kingdom 444 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparationsTechnical testing and analysisOther business support service activities n.e.c.

Previous Company Names

PATHEON LIMITED 29 Apr 1999 — 2 Jul 1999
Accounts Submitted 27 Dec 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 29 Apr 2026 Next due 10 May 2027 10 months remaining
Net assets £803M £103M 2024 year on year
Total assets £1,430M £51M 2024 year on year
Total Liabilities £627M £154M 2024 year on year
Charges 20
20 satisfied

Contact & Details

Contact

Website

www.example.com

Full company profile for PATHEON UK LIMITED (03764421), an active life sciences and medical technology company based in United Kingdom. Incorporated 29 Apr 1999. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£803.31M

Increased by £102.74M (+15%)

Total Liabilities

£626.97M

Decreased by £153.65M (-20%)

Turnover

£784.24M

Decreased by £72.45M (-8%)

Employees

444

Decreased by 109 (-20%)

Debt Ratio

44%

Decreased by 9 (-17%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 3 Shares £51.78m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
14 Feb 20241£49.85m£49.85m
7 Aug 20181£19k£19k
7 Aug 20181£1.91m£1.91m

Officers

Officers

3 active
Status
Drummond, Colin JamesDirectorBritishUnited Kingdom601 Mar 2025Active
Hawkins, PaulDirectorBritishEngland5131 May 2019Active
Mccarthy, RichardDirectorBritishUnited Kingdom5616 Sept 2025Active

Shareholders

Shareholders (2)

Thermo Fisher Scientific (pn1) Uk Limited
95.2%
2,000,000
Thermo Fisher Scientific (pn1) Uk Limited
4.8%
100,005

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Notified 7 Aug 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Patheon N.v.

Ceased 11 Sept 2017

Ceased

Thermo Fisher Scientific Inc.

Ceased 7 Aug 2018

Ceased

Group Structure

Charges

Charges

20 satisfied

Properties

Properties

1 freehold 1 leasehold 2 total
AddressTenurePrice PaidDate Added
151 Brook Drive, Milton Park, Milton, Abingdon (OX14 4SD) VALE OF WHITE HORSE
Leasehold-3 Nov 2021
Patheon Building, Kingfisher Drive, Swindon (SN3 5BZ) SWINDON
Freehold-18 Aug 2010
151 Brook Drive, Milton Park, Milton, Abingdon (OX14 4SD)
Leasehold
Added 3 Nov 2021
District VALE OF WHITE HORSE
Patheon Building, Kingfisher Drive, Swindon (SN3 5BZ)
Freehold
Added 18 Aug 2010
District SWINDON

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026Confirmation StatementConfirmation statement made on 26 Apr 2026 with no updates
27 Dec 2025AccountsAnnual accounts made up to 31 Dec 2024
17 Sept 2025OfficersAppointment of Richard Mccarthy as director on 16 Sept 2025
22 Aug 2025OfficersTermination of Mark Alan Newton as director on 31 Jul 2025
30 Apr 2025Confirmation StatementConfirmation statement made on 26 Apr 2025 with no updates
29 Apr 2026 Confirmation Statement

Confirmation statement made on 26 Apr 2026 with no updates

27 Dec 2025 Accounts

Annual accounts made up to 31 Dec 2024

17 Sept 2025 Officers

Appointment of Richard Mccarthy as director on 16 Sept 2025

22 Aug 2025 Officers

Termination of Mark Alan Newton as director on 31 Jul 2025

30 Apr 2025 Confirmation Statement

Confirmation statement made on 26 Apr 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 26 Apr 2026 with no updates

1 months ago on 29 Apr 2026

Annual accounts made up to 31 Dec 2024

5 months ago on 27 Dec 2025

Appointment of Richard Mccarthy as director on 16 Sept 2025

9 months ago on 17 Sept 2025

Termination of Mark Alan Newton as director on 31 Jul 2025

9 months ago on 22 Aug 2025

Confirmation statement made on 26 Apr 2025 with no updates

1 years ago on 30 Apr 2025